Announced
Synopsis
Altaris, a healthcare investment firm, agreed to acquire Minaris Regenerative Medicine, a global contract development and manufacturing organization, from Resonac, a chemical company. Financial terms were not disclosed. "Minaris operates six facilities across the United States, Germany, and Japan and has more than 500 employees. Through its strategic footprint and manufacturing expertise, Minaris enables leading cell therapy companies to deliver life changing products to patients globally," Altaris.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.